Phase 1, placebo-controlled, single ascending dose trial to evaluate the safety, pharmacokinetics and effect on altered states of consciousness of intranasal BPL-003 (5-methoxy-N,N-dimethyltryptamine benzoate) in healthy participants.

5-methoxy-dimethyltryptamine dry-powder intranasal (BPL-003) - Beckley Psytech

http://www.ncbi.nlm.nih.gov/pubmed/38616411

Allan H Young; Anna O Ermakova; Ben Suttle; Claire Roberts; Fiona Dunbar; Frank Wiegand; James Jonathan Rucker; Mathieu Seynaeve; Takahiro Yamamoto

Apr 15, 2024